NEW YORK (TheStreet) --
Atlas Pipeline Partners (APL) was downgraded to hold at TheStreet Ratings.
Avon (AVP) was initiated with a neutral rating at Credit Suisse. $19 price target. Consensus earnings expectations remain too high, Credit Suisse said.
Great Plains (GXP) was upgraded at Bank of America/Merrill Lynch to buy from underperform. $27 price target. Regulatory outlook is improving, BofA/Merrill said.
Masco (MAS) was upgraded to buy at TheStreet Ratings.
Mead Johnson (MJN) was upgraded at Oppenheimer to outperform from perform. $100 price target. China child policy should be a tailwind for the infant formula business, Oppenheimer said.
Wellcare (WCG) was initiated with a market perform rating at Leerink Swann. $72 price target. CEO suddenly left and the company may struggle to meet consensus earnings expectations, Leerink Swann said.
Stock Comments / EPS Changes
Altera (ALTR) price target was increased at Jefferies. Choice of Intel (INTC - Get Report) product is expected to provide competitive advantage, Jefferies said. $35 price target and hold rating.
Altera was cut from the Conviction Buy List at Goldman Sachs. Company lacks near-term catalysts, Goldman Sachs said. $39 price target.
Brocade (BRCD) estimates, price target were increased at BMO Capital. Estimates were increased through 2015. Company is realizing higher margins, BMO Capital said. Market perform rating and new $9.25 price target.
Chipotle (CMG) price target was increased at Morgan Stanley. Shares are now seen reaching $594. Company deserves a premium multiple, Morgan Stanley said. Overweight rating.
Salesforce.com (CRM) price target was increased at Canaccord Genuity. Company is positioned well for 2014, Canaccord Genuity said. Buy rating.
Salesforce.com price target was increased at UBS. Valuation call with raised revenue projections, UBS said. $66 price target and buy rating.
D.R. Horton (DHI) numbers were lowered at UBS. The company lowered its own numbers across the board, UBS said. Estimates were adjusted to reflect moderate recovery, UBS said. $20 price target and neutral rating.
Envestnet (ENV) EPS and price target were increased at UBS. The company increased its own numbers, UBS said. Driven by health conversion pipeline, strong advisor growth, market tailwinds and tuck-in acquisitions, UBS said. $38 price target and neutral rating.
Health Net (HNT) numbers were reduced at Credit Suisse. Shares are now seen reaching $35. Estimates were also cut, given the company's new guidance, Credit Suisse said. Outperform rating.
Nortek (NTK) price target was increased at Jefferies to $76. Reflects lower share count and interest, Jefferies said. Hold rating.
PNC Financial (PNC) estimates were lowered through 2015 at J.P. Morgan. Slower-than-expected loan growth was partly offset by higher loan loss reserve releases, J.P. Morgan said. Overweight rating.
SunTrust Banks (STI) estimates were lowered at J.P. Morgan through 2015. Slower-than-expected loan growth was partly offset by higher loan loss reserve releases, J.P. Morgan said. Overweight rating.